Events2Join

Boston Scientific closes acquisition of Axonics


Boston Scientific Closes Acquisition of Axonics, Inc. - Nov 15, 2024

MARLBOROUGH, Mass., Nov. 15, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, ...

Boston Scientific finalizes $3.7B acquisition of Axonics - MassDevice

Boston Scientific finalizes $3.7B acquisition of Axonics · A strategic move for Boston Scientific · Boston Scientific transitions Axonics ...

Boston Scientific closes $3.7B Axonics deal after lengthy review

The deal is valued at $71 per share, representing $3.7 billion in equity value and $3.3 billion in enterprise value, according to the Friday ...

Boston Scientific completes $3.7B purchase of California bowel ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a ...

Boston Scientific Closes Acquisition of Axonics, Inc. - Yahoo Finance

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology ...

Boston Scientific Closes $3.7B Deal for Axonics

Boston Scientific began the acquisition deal for Axonics in January 2024. The deal underwent significant scrutiny from the Federal Trade ...

Boston Sci Closes Acquisition of Medtronic's Neuromodulation Foe

After inquiries from FTC, the Marlborough, MA-based has finally closed on acquiring Axonics.

Boston Scientific closes acquisition of Axonics, Inc

Boston Scientific Corporation has announced the close of its acquisition of Axonics, Inc., a medical technology company focused on the ...

Boston Scientific closes acquisition of Axonics - TipRanks.com

Boston Scientific (BSX) announced the close of its acquisition of Axonics (AXNX). The purchase price of $71 cash per share represents an ...

Boston Scientific (BSX) Closes Acquisition of Axonics (AXNX)

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology ...

Boston Scientific Closes Acquisition of Axonics, Inc. - Stock Titan

The $3.7 billion acquisition of Axonics marks a strategic expansion for Boston Scientific into the high-growth sacral neuromodulation market.

Boston Scientific : Closes Acquisition of Axonics, Inc Form 8 K

Boston Scientific Closes Acquisition of Axonics, Inc. MARLBOROUGH, Mass., November 15, 2024 - Boston Scientific Corporation today announced ...

Boston Scientific Closes Acquisition of Axonics

Boston Scientific Closes Acquisition of Axonics ... The company focuses on developing devices to treat urinary and bowel dysfunction. Medical ...

Boston Scientific: Newsroom

Boston Scientific Closes Acquisition of Axonics, Inc. Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc.

Boston Scientific Announces Agreement to Acquire Axonics, Inc.

Boston Scientific acquisition of Axonics to expand urology portfolio with differentiated technologies to treat urinary and bowel dysfunction ...

Boston Scientific (BSX) Completes Acquisition of Axonics - GuruFocus

Boston Scientific Corporation (BSX) has announced the completion of its acquisition of Axonics, Inc., a public medical technology company ...

News Releases - Boston Scientific

Boston Scientific Closes Acquisition of Axonics, Inc. Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc.

Axonics Announces Definitive Agreement to be Acquired by Boston ...

The boards of directors of Axonics and Boston Scientific have unanimously approved the transaction, which is expected to close in the first half ...

News - Boston Scientific EMEA - Home

Boston Scientific Closes Acquisition of Axonics, Inc. Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc.

Boston Scientific still expects Axonics deal to close this year

Boston Scientific agreed to pay $3.7 billion to add the Axonics urology technologies to its portfolio in January. That deal was put on hold, ...